Abiopharma

Baillie Gifford China Growth Trust PLC is an open-end equity mutual fund launched by Witan Investment Services Limited. It is co-managed by Dalton Investments LLC;Aberdeen Asset Managers Limited;Robeco Institutional Asset Management B.V.;Matthews International Capital Management, LLC. It invests in public equity markets of Asia / Pacific region. It invests in stocks of companies operating across diversified sectors. The fund invests in growth stocks of diversified market capitalizations companies. The fund invests in dividend paying stocks of companies. The fund employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the MSCI All Country Asia Pacific Free Index.

Additional info from NASDAQ:
Ford Motor Co. manufactures automobiles under its Ford and Lincoln brands. In March 2022 the company announced that it will run its combustion engine business, Ford Blue, and its BEV business, Ford Model e, as separate businesses but still all under Ford Motor Company. The company has about 12.5% market share in the United States, about 6.5% share in Europe, and about 2.4% share in China including unconsolidated affiliates. We expect market share increases as inventory improves coming out of the chip shortage. Sales in the U.S. made up about 64% of 2021 total company revenue. Ford has about 183,000 employees, including about 56,000 UAW employees, and is based in Dearborn, Michigan.

Additional info from OTC:
Baillie Gifford China Growth Trust PLC is an open-end equity mutual fund launched by Witan Investment Services Limited. It is co-managed by Dalton Investments LLC;Aberdeen Asset Managers Limited;Robeco Institutional Asset Management B.V.;Matthews International Capital Management, LLC. It invests in public equity markets of Asia / Pacific region. It invests in stocks of companies operating across diversified sectors. The fund invests in growth stocks of diversified market capitalizations companies. The fund invests in dividend paying stocks of companies. The fund employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the MSCI All Country Asia Pacific Free Index.